# OnCo record nct06535607 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06535607/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06535607", "NCT06535607" ;
  schema:name "Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors"@en ;
  schema:alternateName "eVOLVE-02"@en ;
  schema:description "A phase 2 trial of Cisplatin, Carboplatin, Paclitaxel / nab-paclitaxel in cervical cancer and head and neck squamous cell carcinoma, run by AstraZeneca, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06535607/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06535607> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2024-08-22" ;
  onco:cancers <https://onco.cc/cancers/cervical/>, <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/mesothelioma/> ;
  onco:drugs <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/flot/> ;
  onco:companies <https://onco.cc/companies/astrazeneca/> .